Goldman Sachs Asset Management (GSAM) has launched an equity fund based around innovation in the healthcare sector.
Four key areas of focus in the fund are genomics, precision medicine, minimally invasive procedures, and digitisation.
The Goldman Sachs Future Health Care Equity Portfolio is a sub-fud of the firm’s Luxembourg-domiciled funds Sicav, and available across Europe.
Luke Barrs, regional head of GSAM fundamental equity client portfolio management, said the pandemic has “supercharged an existing secular trend, and pushed healthcare right to the top of governments’ and societies’ priorities”.
“Specific scientific advancements – the mapping of the human genome, the application of technology to all kinds of medical procedures and increasing digitisation – is disrupting the way society has been practicing medicine for decades,” he added.
©2020 funds europe
